$ERYP #Erytech Pharma SA Erytec Pharma : Update on phase II of Investigator Sponsored Trial in ALL: &gt;Finalisation of patient enrolment and encouraging initial results - This morning, Erytech provide an update on phase II of the trial… https://t.co/SVGjmPpLGJ #equity #stocks https://t.co/iF1za8BHLy